All sources cited by UW refer to NSTEMI - while other ACS do receive DAPT, I could not find good evidence on specific benefits…@Ahmed7 @Cameron @thomas.holmes @Sameem @zarathustra @Eli.Tanenbaum @shmuelsash
I think stick with UWorld for this since it’s what tested. Maybe edit extra to say that “DAPT should be administered to all patients with any ACS and no contraindications (e.g…) but only has demonstrated x benefit with NSTEMI”, if I’m understanding correctly?
think we can keep original
Harrison’s classifies NSTEMI and UA together in NSTE-ACS, and mentions same line of treatment for both. It also mentions DAPT for STEMI post-PCI for prevention of re-occlusion.
Support.
Did more research on ACA/AHA suggestions, all ACS patients are recommended to get DAPT even if no stent is placed - plan to edit and push unless anyone objects @anking-maintainers
(https://professional.heart.org/-/media/PHD-Files/Education/dual_antiplatelet_therapy_ucm_494128.pdf)
support